Select Committee written evidence reported in the House of Commons on Monday, 29 June 2026 from the Committee of Public Accounts.
Correspondence from the Parliamentary Under-Secretary of State for Public Health and Prevention relating to a contingent liability in respect of the provision and use of Favipiravir
Secondary information
- Type
- Parliamentary committee
- Session
- 2026-27
- Witnesses
- Sharon Hodgson
- Department of Health and Social Care
- Subjects
- Liability Japan Medical treatments Hantavirus Favipiravir
- Contains statistics
- Yes
- Link
- View this Parliamentary committee on committees.parliament.uk
Librarians' tools
- Timestamp
- 2026-06-30 14:58:42 +0100
- URI
- http://data.parliament.uk/selectcommittees/80237
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/selectcommittees/80237
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/selectcommittees/80237
- Internal location
- http://oasis.parliament.uk/OasisDocument/view/80237